Skip to main content
. 2022 Mar 7;13:845988. doi: 10.3389/fimmu.2022.845988

Figure 3.

Figure 3

Mortality in RP-ILD in anti-MDA5 and anti-ARS positive DM and prognostic value of serum ferritin Survival analysis in RP-ILD patients with anti-MDA5 or anti-ARS antibodies (A) and prognostic value of serum ferritin in MDA5+DM (B).